Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2023 (specifically covering events on February 13 and February 15, 2023)
Context: This filing serves to furnish two press releases (Exhibits 99.1 and 99.2) issued by the Company. The information contained in these exhibits is furnished and not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a procedural submission referencing attached press releases and does not contain a financial statement or quantitative data within the provided text.
Material Changes
The filing does not detail specific material changes in financial performance or operations within the text body. It solely references the issuance of press releases on February 13 and February 15, 2023, the content of which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It explicitly states that the attached press releases are not incorporated by reference into other filings unless expressly set forth by specific reference.
Investor Verification Checklist
- Review the full text of the attached press releases (Exhibits 99.1 and 99.2) to understand the specific events reported on February 13 and February 15, 2023.
- Verify if the content of the press releases has been incorporated by reference in other SEC filings, as this Form 6-K states they are not automatically incorporated.
- Confirm the identity of the signatory, Michael McGarrity, as the Chief Executive Officer authorizing the report.